Merck Collaborates with Medisafe to Improve Medication Adherence

coherentnews

Merck announced collaboration with US-based Medisafe, which aims to help cardiometabolic patients in managing medication intake and adherence to prescribed treatment through digital offering

Merck patients from various countries will be able to access a customized version of Medisafe’s mobile platform. The digital platform will combine reminders, motivation and support systems, targeted content, coupons, and interventions in their local language. This digital solution will complement Merck’s current offering of Primary Care medicines for cardiometabolic conditions, which includes treatments for type 2 diabetes, thyroid disorders, and cardiovascular diseases.

The first three countries where patients receiving Merck’s primary care medicines will have access to a customized version of Medisafe will be Brazil, Russia, and Mexico. Medisafe is a medication management and adherence solution that is invested by mVentures. Its mobile platform was named top app for medication management by November 2017 IQVIA (Quintiles IMS) report and has received endorsements from the American Pharmacy Association, Journal of Medical Internet Research (JMIR), and Ranked Health. “We are confident that offering such a solution to our patients has the potential to significantly improve medication adherence by giving patients and healthcare providers tools to organize, understand and manage their medications,” said Simon Sturge, chief operating officer at Merck´s Biopharma business.

The full benefits of medications in the treatment of chronic diseases are not realized by patients due to poor adherence to treatment regimens. Factors that contribute to poor medication adherence are many and include those that are related to patients, physicians, and healthcare systems. As a result, understanding of the underlying causes of poor medication adherence is limited. The collaboration is expected to provide overall insights for patient behaviors through aggregated and de-identified data collected by Medisafe to improve chronic disease management.

You may be interested

Single Cell Analysis Market : Global Sales, Ex-factory Price, Revenue, Gross Margin Analysis 2026
Healthcare
Healthcare

Single Cell Analysis Market : Global Sales, Ex-factory Price, Revenue, Gross Margin Analysis 2026

Mohit Joshi - October 16, 2018

The Single Cell Analysis Market is expected to have a highly positive outlook for the next eight years 2018-2026 according to a recently released Single Cell Analysis Market research report. The…

Audiology Devices Market Expansion to be Persistent During 2026
Healthcare
Healthcare

Audiology Devices Market Expansion to be Persistent During 2026

Mohit Joshi - October 16, 2018

The Audiology Devices Market is expected to have a highly positive outlook for the next eight years 2018-2026 according to a recently released Audiology Devices Market research report. The report has…

Ophthalmic Devices Market : Moving Towards a Brighter Future
Healthcare
Healthcare

Ophthalmic Devices Market : Moving Towards a Brighter Future

Mohit Joshi - October 16, 2018

The Ophthalmic Devices Market is expected to have a highly positive outlook for the next eight years 2018-2026 according to a recently released Ophthalmic Devices Market research report. The report has…

Most from this category